Fortune Apex Development

Fortune Apex Development is a biotechnology company specializing in advanced mucosal drug delivery systems, primarily through its proprietary MucoAdhesive Technology (MUCOAD). The company's platform is designed to enhance the delivery of pharmaceuticals via the nasal and pulmonary routes, offering improved bioavailability and patient compliance compared to traditional administration methods. Its lead commercial product is Sinol-M, a capsaicin-based nasal spray for the treatment of allergic rhinitis and sinusitis, which is marketed through strategic partnerships. Additionally, Fortune Apex developed the X-HALO device, a non-invasive diagnostic tool that monitors exhaled breath temperature to manage airway inflammation in respiratory conditions like asthma. The company operates as an intellectual property-focused entity, leveraging joint ventures and licensing agreements to commercialize its respiratory and diagnostic technologies globally.